Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$167.66M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Anbio Biotechnology Class A Ordinary SharesAnbio Biotechnology Class A Ordinary Shares19.8-24%--
$0.32

Current Fair Value

91% downside

Overvalued by 91% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$167.66 Million
Enterprise Value$159.90 Million
Earnings per Share$0.16
Beta5.67
Outstanding Shares43,891,200

Return

Return on Equity23.76%ROE
Return on Assets23.69%
Return on Invested Capital21.07%

Valuation & Multiples

P/E Ratio19.75P/E Ratio
PEG-6PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue11.18
Enterprise Value to EBIT25.17
Enterprise Value to Net Income22
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.24%▲ 0.08%
Total Invested$676,193▼ 31.36%
Investors Holding14▲ 2.00%

About Anbio Biotechnology Class A Ordinary Shares

27 employees
CEO: Michael Lau

Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia...